Evidence map›Paper›PMID 32017532›Full record

ArticleACS chemical biology2020

Structure-Guided Design and In-Cell Target Profiling of a Cell-Active Target Engagement Probe for PARP Inhibitors.

Ryan T Howard, Paul Hemsley, Philip Petteruti, Charlie N Saunders, Javier A Molina Bermejo, James S Scott, Jeffrey W Johannes, Edward W Tate

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Proteome-Wide Profiling of Olaparib Interactors Using a Biotinylated Photoaffinity Probe.Chembiochem : a European journal of chemical biology · 2025
    Article
  3. Article
  4. Article
  5. Chemoproteomics, A Broad Avenue to Target Deconvolution.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  6. Novel anti-Frontiers in cellular and infection microbiology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Functional roles of ADP-ribosylation writers, readers and erasers.Frontiers in cell and developmental biology · 2022
    Review
  11. Article
  12. Review
  13. Olaparib-Based Photoaffinity Probes for PARP-1 Detection in Living Cells.Chembiochem : a European journal of chemical biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ryan T HowardDepartment of Chemistry, Molecular Sciences Research Hub , Imperial College London , London W12 0BZ , United Kingdom.
Paul HemsleyOncology, R&D , AstraZeneca , Cambridge CB4 0WG , United Kingdom.
Philip PetterutiOncology, R&D , AstraZeneca, Boston , Waltham , Massachusetts 02451 , United States.
Charlie N SaundersDepartment of Chemistry, Molecular Sciences Research Hub , Imperial College London , London W12 0BZ , United Kingdom.
Javier A Molina BermejoDepartment of Chemistry, Molecular Sciences Research Hub , Imperial College London , London W12 0BZ , United Kingdom.
James S ScottOncology, R&D , AstraZeneca , Cambridge CB4 0WG , United Kingdom.ORCID 0000-0002-2263-7024
Jeffrey W JohannesOncology, R&D , AstraZeneca, Boston , Waltham , Massachusetts 02451 , United States.ORCID 0000-0001-7242-6682
Edward W TateDepartment of Chemistry, Molecular Sciences Research Hub , Imperial College London , London W12 0BZ , United Kingdom.ORCID 0000-0003-2213-5814
Imperial College London · GBAstraZeneca (United Kingdom) · GBAstraZeneca (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition of the poly(ADP-ribose) polymerase (PARP) family of enzymes has become an attractive therapeutic strategy in oncology and beyond; however, chemical tools to profile PARP engagement in live cells are lacking. Herein, we report the design and application of

Indexed as

AziridinesCell Line, TumorHumansPhotoaffinity LabelsPhthalazinesPiperazinesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesProteomicsUltraviolet RaysAZ0108AziridinesolaparibPARP1 protein, humanPARP2 protein, humanPhotoaffinity LabelsPhthalazinesPiperazinesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) Polymerases

Identifiers

PMID32017532
PMCPMC7146755
OpenAlexW3004552885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.